Semi-Annual Consolidated Statement Of Income

Kringle Pharma,Inc. - Filing #7357145

Concept 2023-10-01 to
2023-12-31
2022-10-01 to
2022-12-31
Semi-annual consolidated statement of income
Statement of income
Net sales
18,690,000 JPY
17,365,000 JPY
Cost of sales
JPY
JPY
Ordinary profit (loss)
-169,113,000 JPY
-157,476,000 JPY
Gross profit (loss)
18,690,000 JPY
17,365,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
187,283,000 JPY
174,832,000 JPY
Operating profit (loss)
-168,592,000 JPY
-157,467,000 JPY
Profit (loss) before income taxes
-169,113,000 JPY
-157,476,000 JPY
Non-operating income
Non-operating income
544,000 JPY
JPY
Income taxes - current
372,000 JPY
372,000 JPY
Non-operating expenses
Non-operating expenses
1,064,000 JPY
9,000 JPY
Income taxes
372,000 JPY
372,000 JPY
Profit (loss)
-169,486,000 JPY
-157,849,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.